Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast CancerWieslawa H. Dragowska, Marcel B. Bally|PLoS ONE|2013Cited by 101
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivityWieslawa H. Dragowska, Marcel B. Bally|BMC Cancer|2011Cited by 28
Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In VivoWieslawa H. Dragowska, Ada W.Y. Leung|Pharmaceutics|2024Cited by 4
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy StressWieslawa H. Dragowska, Donald T. Yapp|Scientific Reports|2016Cited by 1